FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia

News   Sep 11, 2012

 
FDA Approves New Orphan Drug for Chronic Myelogenous Leukemia
 
 
 

RELATED ARTICLES

Joint Lab on Artificial Intelligence and Computer Vision Established

News

The Hong Kong University of Science and Technology signed a Memorandum of Understanding with Megvii (Face++) yesterday on establishing a joint laboratory on artificial intelligence (AI) and computer vision. The lab will be dedicated to improving people’s living and advance knowledge frontiers.

READ MORE

Anti-stress Compound Reduces Obesity and Diabetes

News

Scientists could prove that a stress protein found in muscle has a diabetes promoting effect. This finding could pave the way to a completely new treatment approach.

READ MORE

Some Immune Cells May Help Tumors Instead of Destroying Them

News

New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE